Frequency of depression amongst patients with Parkinson disease at tertiary care hospital of Quetta

https://doi.org/10.53730/ijhs.v6nS8.13960

Authors

  • Ghulam Rasool Professor and Executive Director of Psychiatry, Balochistan Institute of Psychiatry and Behavioral Sciences Quetta
  • Zarmina Tareen Assistant Professor, Balochistan Institute of Psychiatry and Behavioral Sciences Quetta

Keywords:

frequency, depression, Parkinson disease

Abstract

Background: Depression and anxiety are frequent mood problems associated with Parkinson disease (PD). The occurrence of mood disorders has, however, only been the subject of a small number of investigations. Objective: To assess the frequency of Depression amongst patients with Parkinson disease at tertiary care hospital of Quetta. Methodology: The current cross sectional study was carried out Balochistan Institute of Psychiatry and Behavioral Sciences and Bolan Medical Complex Hospital Quetta from December 2019 to December 2020. All those individuals were selected for study which has confirmed PD diagnosed by one or more than single Neurophysicians. A standard and well-defined questionnaire was used and then score was assigned using Beck Depression inventory- II (BDI-II) to depression evidences. The SPSS version 24.0 was used to input and analyze the data. Results: In our study, totally 40 patients were enrolled. The male patients were 36 (90%) while female patients were 4 (10%). The mean age (SD) in our study was 52 (11.6) years. 

Downloads

Download data is not yet available.

References

Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P (2012) Depression in Parkinson disease–epidemiology, mechanisms and management. Nat Rev Neurol 2012, 11:35–47.

Alhadi AN, Alarabi MA, Alshomrani AT, Shuqdar RM, Alsuwaidan MT, McIntyre RS. Arabic translation, validation and cultural adaptation of the 7item Hamilton depression rating scale in two community samples. SQUMJ. 2018;18:2.

Aslam MA, Imam SF, Khawar S, and Numan (2016) A Prevalence of Depression in Patients with Parkinson’s Disease. J F J M C.10:105.

Broen MP, Kohler S, Moonen AJ, Kuijf ML, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Leentjens AF. Modeling anxiety in Parkinson's disease. Mov Disord. 2016;31(3):310–6

Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF. Prevalence of anxiety in Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2016;31(8):1125–33

Chuquilín-Arista F, Álvarez-Avellón T, Menéndez-González M. Prevalence of depression and anxiety in Parkinson disease and impact on quality of life: a community-based study in Spain. J Geriatr Psychiatry Neurol. 2020;33(4): 207– 13.

Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149:443–454.

Ehrt U, Bronnick K, Leentjens AF, Larsen JP, Aarsland D. Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease. Int. J. Geriatr. Psychiatry. 2006;21:252-8.

El-Tallawy HN, Farghaly WM, Shehata GA, Rageh TA, Hakeem NM, Hamed MA, et al. Prevalence of Parkinson's disease and other types of Parkinsonism in Al Kharga district, Egypt. Neuropsychiatr. Dis. Treat. 2013;9:1821-6.

Hallit S, Haddad C, Hallit R, Akel M, Obeid S, Haddad G, et al. Validation of the Hamilton anxiety rating scale and state trait anxiety inventory a and B in Arabic among the Lebanese population. Clin Epidemiol Glob Health. 2019;7(3):464–70.

Kang HJ, Bae KY, Kim SW, Shin IS, Yoon JS, Kim JM. Anxiety symptoms in Korean elderly individuals: a two-year longitudinal community study. Int Psychogeriatr. 2016;28(3):423–33.

Ketharanathan T, Hanwella R, Weerasundera R, de Silva VA. Major depressive disorder in Parkinson's disease: a cross-sectional study from Sri Lanka. BMC Psychiatry. 2014;14:278.

Khealani BA and Baig SM (2006) Clinical spectrum of Parkinsns disease from Pakistan. Singapore med j; 47: 1075-1079.

Li N, Chen G, Zeng P, Pang J, Gong H, Han Y, Zhang Y, Zhang E, Zhang T, Zheng X. Prevalence of depression and its associated factors among Chinese elderly people: a comparison study between community-based population and hospitalized population. Psychiatry Res. 2016;243:87–91.

Merschdorf U, Berg D, Csoti I, Fornadi F, Merz B, Naumann M, et al. Psychopathological symptoms of depression in Parkinson's disease compared to major depression. Psychopathology. 2003;36:221-5.

Pontone GM. Anxiety in Parkinson's: a complex syndrome of nondopaminergic and dopaminergic etiology. Eur J Neurol. 2017;24(4):541–2.

Ragab OA, Elheneedy YA, Bahnasy WS. Non-motor symptoms in newly diagnosed Parkinson’s disease patients. Egypt J Neurol Psychiatr Neurosurg. 2019;55(1):24.

Rihmer Z, Gonda X, Dome P. Depression in Parkinson's disease. Ideggyogyaszati szemle. 2014;67:229-36.

Sagna A, Gallo JJ, Pontone GM. Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease. Parkinsonism Relat Disord. 2018;20(7):708–15.

Shalash AS, Hamid E, Elrassas HH, Bedair AS, Abushouk AI, Khamis M, et al. Non-motor symptoms as predictors of quality of life in Egyptian patients with Parkinson’s disease: a cross-sectional study using a culturally adapted 39-item Parkinson's disease questionnaire. Front Neurol. 2018;9:357.

Shulman LM, Taback RL, Bean J, Weiner WJ (2001) Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord 16:507–510.

Talreja AK, Kumar H, Essrani RK, Lal C, Arwani S (2016) Prevalence of Depression in Patients of Parkinson’s Disease Presenting to a Tertiary Care Hospital at Karachi. J Neurol Stroke 4(4): 00138.

Timmer M, van Beek M, Bloem B, Esselink R. What a neurologist should know about depression in Parkinson’s disease. Pract Neurol. 2017;17:359–68.

Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am. J. Geriatr. Psychiatry. 2006;14:169-75.

Williams JR, Hirsch ES, Anderson K, Bush AL, Goldstein SR, Grill S, et al. A comparison of nine scales to detect depression in Parkinson disease: which scale to use? Neurology. 2012;78:998-1006.

Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur. J. Epidemiol. 2011;26 Suppl 1:S1-58.

Wu T, Du Y, Han J, Singh S, Xie C, et al. (2013) Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis. Mol Cell Proteomics 12(5: 1170-1179.

Zheng J, Yang X, Zhao Q, Tian S, Huang H, Chen Y, et al. Association between gene polymorphism and depression in Parkinson’s disease: a casecontrol study. J Neurol Sci. 2017;375:231–4.

Published

30-09-2022

How to Cite

Rasool, G., & Tareen, Z. (2022). Frequency of depression amongst patients with Parkinson disease at tertiary care hospital of Quetta. International Journal of Health Sciences, 6(S8), 6703–6709. https://doi.org/10.53730/ijhs.v6nS8.13960

Issue

Section

Peer Review Articles